Home | About Us | Contact Us
Best Seller
Opportunities in Indian Healthcare Sector By RNCOS
Search by Keyword

All Research Reports

Latest Research by Email
Receive email alerts of new market research reports in your industry.

Contact Us
US:+1 (646) 3678214
India:+91 (11) 42141228
E-mail: sales@marketsmonitor.com

Global Pharmaceutical Market Forecast to 2012

Publisher: RNCOS Publish Date:  Dec, 2009 No. of Pages: 170
Delivery: Adobe Reader (PDF) Upto 24 hour delivery
Global Pharmaceutical Market Forecast to 2012
  Multiple Users(Electronic Access) or Global Site license US$ 2800.00
  Soft Copy (CD-ROM) US$ 2100.00
  Hard Copy US$ 2100.00
  Electronic Access - Single User PDF US$ 1800.00
Abstract
Table of Content
List of Figures & Tables
Related Reports

1. Analyst View

2. Global Pharmaceutical Market: An Overview
     2.1 Market Size & Growth
     2.2 Geographical Performance
     2.3 Leading Therapy Classes
     2.4 Leading Drugs
     2.5 Leading Pharmaceutical Companies

3. Market by Region
     3.1 North America
           3.1.1 US
           3.1.2 Canada
     3.2 Latin America
           3.2.1 Brazil
           3.2.2 Mexico
           3.2.3 Argentina
           3.2.4 Chile
     3.3 Europe
           3.3.1 Germany
           3.3.2 France
           3.3.3 Italy
           3.3.4 Spain
           3.3.5 UK
           3.3.6 Russia
           3.3.7 Turkey
           3.3.8 Poland
           3.3.9 Hungary
           3.3.10 Ukraine
           3.3.11 Czech Republic
           3.3.12 Romania
     3.4 Asia-Pacific
           3.4.1 India
           3.4.2 China
           3.4.3 Japan
           3.4.4 South Korea
           3.4.5 Indonesia
           3.4.6 Vietnam
           3.4.7 Thailand
           3.4.8 Philippines
           3.4.9 Malaysia
           3.4.10 Saudi Arabia
           3.4.11 UAE
           3.4.12 Australia
           3.4.13 New Zealand
     3.5 Africa
           3.5.1 South Africa
           3.5.2 Egypt
           3.5.3 Nigeria

4. Key Player Profiles
     4.1 Pfizer Inc
     4.2 Sanofi-Aventis
     4.3 GlaxoSmithKline plc
     4.4 Novartis International AG
     4.5 AstraZeneca Plc